U.K., July 30 -- Sema4 is a Stamford, Connecticut-based healthcare intelligence company, using data analysis to help improve the diagnosis and treatment of disease.
The company says its mission is to use the models it produces to transform healthcare. Its platform, Centrellis, analyses healthcare data to optimise care, initially in reproductive health. The company recently launched a family of products known as Sema4 Signal, with a new focus on oncology.
Sema4 also said it was participating in the response to the ongoing COVID-19 pandemic by providing a "holistic" testing platform, making use of the expertise it has acquired.
Since being founded in 2017, the company has raised $241mn across two funding rounds. Its latest Series C round, ...